Intensity modulated radiotherapy matches proton beam therapy for head and neck cancer: Study Dr. Kamal Kant Kohli9 Oct 2025 9:15 PM ISTIntensity-modulated radiotherapy is as good as proton beam therapy for treating people with head and neck cancer, according to the results of a Cancer...
High Sucralose Intake May Lower Effectiveness of Immune Checkpoint Inhibitors in Cancer Patients: Study Dr Riya Dave8 Oct 2025 8:15 PM ISTResearch published in Cancer Discovery suggests that high consumption of the artificial sweetener sucralose may reduce the effectiveness of immune...
FDA Authorizes ProSense Cryoablation System for Early-Stage Breast Cancer in Older Women Dr. Kamal Kant Kohli7 Oct 2025 8:30 PM ISTThe FDA has granted marketing authorization for the ProSense Cryoablation System by IceCure for the treatment of small, early-stage breast cancer in...
9/11 study shows how toxic exposures may lead to blood cancers Dr. Kamal Kant Kohli7 Oct 2025 6:30 AM ISTA study led by researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) has found that...
Inflammation Markers Help Predict AKI After Bladder Cancer Surgery, reports study Dr Riya Dave5 Oct 2025 8:30 PM ISTResearchers have identified in a new study that perioperative dynamic alterations in systemic inflammatory markers are highly correlated with acute...
Radiation exposure from imaging in children increased risk of hematologic cancer: NEJM Jacinthlyn Sylvia4 Oct 2025 9:15 PM ISTA new study published in The New England Journal of Medicine showed a link between radiation exposure from medical imaging and a tiny but considerable...
Adjuvant Radiotherapy or ET Lowers Locoregional Recurrence Rates Risk in Early-Stage Breast Cancer: JAMA Medha Baranwal3 Oct 2025 9:00 PM ISTUSA: Researchers have found in a new study that adjuvant radiotherapy (RT) or endocrine therapy (ET) significantly reduces the risk of locoregional...
Roche bags USFDA nod for Tecentriq plus lurbinectedin for extensive-stage small cell lung cancer Ruchika Sharma3 Oct 2025 1:11 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) and Tecentriq Hybreza...
Pneumococcal Vaccination in Hematological Malignancies (HM)-Indian Hematology Expert Consensus 2025 Dr. Kamal Kant Kohli3 Oct 2025 11:59 AM ISTPneumococcal vaccination is strongly recommended for patients with specific hematological malignancies, a recently released Indian hematology expert...
Radiation therapy after surgery safely reduces pelvic relapse risk from locally advanced, muscle-invasive bladder cancer: Study Dr. Kamal Kant Kohli2 Oct 2025 9:00 PM ISTRadiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer,...
Sugary drinks may increase risk of metastasis in advanced colorectal cancer, reveals research Dr. Kamal Kant Kohli1 Oct 2025 8:15 PM IST A new study from researchers at The University of Texas MD Anderson Cancer Center shows that the glucose-fructose mix found in sugary drinks...
Biocon Biologics, Amgen strike settlement, clear path for Bosaya, Aukelso in US Ruchika Sharma1 Oct 2025 12:05 PM ISTBengaluru: Biocon Biologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced a settlement...
